Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Splenomegaly CLINICAL MANIFESTATIONS. A soft, thin spleen may be palpable in 15% of neonates, 10% of normal children, and 5% of adolescents. In most individuals, the spleen must be 2–3 times its normal size before it is palpable. Superficial abdominal venous distention may be present when splenomegaly is a result of portal hypertension. Radiologic detection or confirmation of splenic enlargement is done with ultrasonography, CT, or technetium-99 sulfur colloid scan. The latter also assesses splenic function. DIFFERENTIAL DIAGNOSIS. Differential Diagnosis of Splenomegaly by Pathophysiology ANATOMIC LESIONS Severe hemolytic anemias Hamartomas Myeloproliferative diseases: chronic myelogenous leukemia (CML), juvenile CML, myelofibrosis with myeloid metaplasia, polycythemia vera Polysplenia syndrome Osteopetrosis Hemangiomas and lymphangiomas Patients receiving granulocyte and granulocytemacrophage colony-stimulating factors Cysts, pseudocysts Hematoma or rupture (traumatic) HYPERPLASIA CAUSED BY HEMATOLOGIC DISORDERS Acute and Chronic Hemolysis [*] Hemoglobinopathies (sickle cell disease in infancy with or without sequestration crisis and sickle variants, thalassemia major, unstable hemoglobins) Erythrocyte membrane disorders (hereditary spherocytosis, elliptocytosis, pyropoikilocytosis) INFECTIONS[†] Bacterial Acute sepsis: Salmonella typhi, Streptococcus pneumoniae, Haemophilus influenzae type b, Staphylococcus aureus Chronic infections: infective endocarditis, chronic meningococcemia, brucellosis, tularemia, catscratch disease Immune hemolysis (autoimmune and isoimmune hemolysis) Local infections: splenic abscess (S. aureus, streptococci, less often Salmonella species, polymicrobial species), pyogenic liver abscess (anaerobic bacteria, gram-negative enteric bacteria), cholangitis Paroxysmal nocturnal hemoglobinuria Viral[*] Chronic Iron Deficiency Acute viral infections, especially in children Extramedullary hematopoiesis Congenital cytomegalovirus (CMV), herpes simplex, Erythrocyte enzyme deficiencies (severe G6PD deficiency, pyruvate kinase deficiency) rubella Mixed connective tissue disease Hepatitis, A, B, and C;CMV Systemic vasculitis Epstein-Barr virus (EBV) Serum sickness Viral hemophagocytic syndromes: CMV, EBV, HHV-6 Drug hypersensitivity, especially to phenytoin Human immunodeficiency virus (HIV) Graft vs host disease Spirochetal Sjögren syndrome Syphilis, especially congenital syphilis Cryoglobulinemia Leptospirosis Amyloidosis Rickettsial Sarcoidosis Rocky Mountain spotted fever Large granular lymphocytosis and neutropenia Q fever Histiocytosis syndromes Typhus Hemophagocytic syndromes (nonviral, familial) Fungal/Mycobacterial MALIGNANCIES Miliary tuberculosis Primary: leukemia (acute, chronic), lymphoma, angiosarcoma, Hodgkin disease Disseminated histoplasmosis Metastatic South American blastomycosis Systemic patients) candidiasis (in STORAGE DISEASES immunosuppressed Parasitic Lipidosis (Gaucher disease, Niemann-Pick disease, infantile GM1 gangliosidosis) Malaria Mucopolysaccharidoses (Hurler, Hunter-type) Toxoplasmosis, especially congenital Mucolipidosis (I-cell disease, sialidosis, multiple sulfatase deficiency, fucosidosis) Toxocara canis, Toxocara cati (visceral larva migrans) Leishmaniasis (kala-azar) Defects in carbohydrate metabolism: galactosemia, fructose intolerance Schistosomiasis (hepatic-portal involvement) Sea-blue histiocyte syndrome Trypanosomiasis Fascioliasis IMMUNOLOGIC AND INFLAMMATORY PROCESSES[*] Systemic lupus erythematosus Rheumatoid arthritis CONGESTIVE[*] Heart failure Intrahepatic cirrhosis or fibrosis Extrahepatic portal (thrombosis), splenic, and hepatic vein obstruction (thrombosis, Budd-Chiari syndrome) * Common. † Chronic or recurrent infection suggests underlying immunodeficiency. Pseudosplenomegaly. Abnormally enlarged mesenteric connections may produce a wandering or ptotic spleen. An enlarged left lobe of the liver, a left upper quadrant mass, or a splenic hematoma may be mistaken for splenomegaly. Splenic cysts may contribute to splenomegaly or mimic it; these may be congenital (epidermoid) or acquired (pseudocyst) after trauma or infarction. Cysts are usually asymptomatic and are found on radiologic evaluation. Splenosis after splenic rupture or an accessory spleen (present in 10% of normal individuals) may also mimic splenomegaly; most are not palpable. The syndrome of congenital polysplenism includes : cardiac defects, left-sided organ anomalies, bilobed lungs, biliary atresia, and pseudosplenomegaly Hypersplenism. Increased splenic function (sequestration or destruction of circulating cells) results in : 1. peripheral blood cytopenia, 2. increased bone marrow activity, and 3. splenomegaly. It is usually secondary to another disease and may be cured by treatment of the underlying condition or, if absolutely necessary, moderated by splenectomy. Congestive Splenomegaly (Banti Syndrome). Splenomegaly may result from obstruction in the hepatic, portal, or splenic veins. Wilson disease , galactosemia , biliary atresia , and α-antitrypsin deficiency may result in hepatic inflammation, fibrosis, and vascular obstruction. Congenital abnormalities of the portal (absent or hypoplastic) or splenic veins may cause vascular obstruction. Septic omphalitis or thrombophlebitis may be spontaneous or may occur as a result of umbilical venous catheterization in neonates and may also result in secondary obliteration of these vessels. Splenic venous flow may be obstructed by masses of sickled erythrocytes. When the spleen is the site of vascular obstruction, splenectomy cures hypersplenism. However, the obstruction usually is in the hepatic or portal systems. In these latter cases, portocaval shunting may be more helpful, because both portal hypertension and thrombocytopenia contribute to variceal bleeding.